RxDoctor Payments DataLook up a doctor →

William Sargeant

Adult Medicine · Montgomery, ALNPI 1235159435

Payments from drug & device makers

$1,040,360in general payments, 2019–2025

Across 1,353 payments — averaging $768.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$1M
  • Boehringer Ingelheim$19K
  • GSK$13K
  • Amarin Pharma, Inc.$608
  • Novo Nordisk$520
  • Amgen$434
  • plus $3K from 27 others
$50in research payments, 2019–2025

Across 1 payment — averaging $50.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novo Nordisk AS$50

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,040,360 in reported general payments places this provider in the 95th percentile of 26 adult medicine providers in Alabama.

See all adult medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$41,368
Medicare patients
54
Services billed
2,545

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult medicine in Montgomery

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →